SciELO - Scientific Electronic Library Online

 
vol.20 número1Análisis de la casuística de los pacientes derivables desde urgencias a atención primariaEvaluación económica del tratamiento con ácido acetilsalicílico más esomeprazol comparado con clopidogrel en la prevención de la hemorragia gastrointestinal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Gaceta Sanitaria

versión impresa ISSN 0213-9111

Resumen

MAR, Javier; GUTIERREZ-MORENO, Santiago  y  CHILCOTT, Jim. Probabilistic cost-effectiveness analysis of the treatment of sleep apnea. Gac Sanit [online]. 2006, vol.20, n.1, pp.47-53. ISSN 0213-9111.

Objective: To describe the application of a probabilistic cost-effectiveness analysis to nasal continuous positive airway passage (nCPAP) treatment of obstructive sleep apnea syndrome (OSAS). Material and Methods: The probabilistic model was constructed from a discrete Markov model. This probabilistic approach is characterized by the introduction of variables as probability distributions. The model performed 2,000 Monte Carlo simulations, and incremental costs and effectiveness were calculated in each. The results were analyzed through the cost-effectiveness plane, the acceptability curve, the net benefit rule, and the expected value of perfect information (EVPI). Results: The mean cost-effectiveness ratio for nCPAP treatment was 5,480 S/QALY (quality-adjusted life year). Using an acceptability threshold of 30,000 €/QALY, the probabilistic analysis showed that nCPAP was the optimal treatment in 98.5% of the simulations. The EVPI showed that the parameter causing greatest uncertainty in the final results was the quality of life gain through nCPAP treatment. Conclusions: The results of our probabilistic analysis are endorsed by previous deterministic studies confirming that nCPAP treatment of OSAS is the most cost-effective strategy. An additional advantage of probabilistic analysis is that it allows uncertainty to be quantified; in the present case the probability of making the wrong decision was below 5%. Furthermore, this study reveals that to reduce uncertainty, research should center on improving information on quality of life.

Palabras clave : Obstructive sleep apnea syndrome; Treatment; Cost-effectiveness analysis; Monte Carlo simulations.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons